Related Experiment Video
Updated: Jan 23, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Psychiatry
Shinji Sakamoto1, Hiroki Kawai, Yuko Okahisa
1Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.shinjisakamoto1202@gmail.com.
Abstract:
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a recently-discovered autoimmune disorder in which antibodies target NMDAR in the brain. The number of reported cases of anti-NMDAR encephalitis has increased rapidly. Anti-NMDAR encephalitis can be mistakenly diagnosed as psychiatric disorders because many patients present with prominent psychiatric symptoms and visit psychiatric institutions first. Thus, psychiatrists should cultivate a better understanding of anti-NMDAR encephalitis. In this review, we present the mechanisms, epidemiology, symptoms and clinical course, diagnostic tests, treatment and outcomes of patients with anti-NMDAR encephalitis. Furthermore, we discuss the diversity of clinical spectra of anti-NMDAR encephalitis, and demonstrate a differential diagnosis of psychiatric disease from the perspective of psychiatry.
Insights
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder where brain antibodies target NMDAR. Recognizing its psychiatric symptoms is crucial for accurate diagnosis and treatment.
Area of Science:
- Neurology
- Immunology
- Psychiatry
Background:
- Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune neurological disorder.
- Increasing case reports highlight its growing prevalence.
- Prominent psychiatric symptoms often lead to misdiagnosis in psychiatric settings.
Purpose of the Study:
- To provide a comprehensive review of anti-NMDAR encephalitis.
- To enhance psychiatrists' understanding of this condition.
- To discuss differential diagnosis from a psychiatric perspective.
Main Methods:
- Review of existing literature on anti-NMDAR encephalitis.
- Analysis of mechanisms, epidemiology, clinical presentation, diagnosis, and treatment.
- Exploration of the diverse clinical spectrum and psychiatric manifestations.
Main Results:
- Anti-NMDAR encephalitis presents with a wide range of symptoms, often mimicking psychiatric disorders.
- Early recognition and diagnosis are critical for effective management.
- Treatment strategies and patient outcomes are varied.
Conclusions:
- A thorough understanding of anti-NMDAR encephalitis is essential for psychiatrists.
- Distinguishing it from primary psychiatric conditions improves patient care.
- Further research into its diverse clinical presentations is warranted.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
09:25Anti-RDL and Anti-mGlutR1 Receptors Antibody Testing in Honeybee Brain Sections using CRISPR-Cas9
Published on: January 30, 2020
Related Concept Videos
Internal Receptors
Receptor-mediated Endocytosis
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
G-protein Coupled Receptors
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...